ERA Banner
Download Add to Cart Share
More Like This
  • Role of CYP-mediated Arachidonic Acid Metabolites in Development of Cardiac Hypertrophy and Chronic Doxorubicin-induced Cardiotoxicity
  • Alsaad,Abdulaziz M
  • English
  • Arachidonic acid
    cardiac hypertrophy
  • Oct 23, 2012 3:05 PM
  • Thesis
  • English
  • Adobe PDF
  • 4089320 bytes
  • Drug-induced cardiotoxicity is classified as a predisposing factor leading to cardiac hypertrophy and heart failure. Of importance, doxorubicin (DOX, adriamycin) is considered as an effective anticancer agent whose major limiting side effect is cardiotoxicity. Of importance, several studies showed that acute DOX cardiotoxicity alters cytochrome P450 (CYP)-mediated arachidonic acid (AA) metabolism. However, the clinical situation involves chronic drug administration. Therefore, we investigated the effect of chronic DOX treatment on expression of cardiac CYP enzymes and CYP-mediated AA metabolism in male Sprague–Dawley (SD) rats. Our results showed that chronic DOX treatment significantly induced gene expression and activity of CYP ω-hyroxylase and soluble epoxide hydrolase (sEH) enzymes. Inhibition of these enzymes significantly prevented DOX-mediated induction of hypertrophic markers in H9c2 cells confirming the role of these enzymes in DOX cardiotoxicity. In conclusion, CYP ω-hyroxylase and sEH enzymes might be considered as novel targets to treat and/or to protect against DOX cardiotoxicity.
  • Alsaad, A. M., Zordoky, B. N., El-Sherbeni, A. A., & El-Kadi, A. O. (2012). Chronic Doxorubicin cardiotoxicity modulates cardiac cytochrome p450-mediated arachidonic Acid metabolism in rats. Drug metabolism and disposition: the biological fate of chemicals, 40, 2126-2135.
  • Master's
  • Master of Science
  • Faculty of Pharmacy and Pharmaceutical Sciences
  • Pharmaceutical Sciences
  • Spring 2013
  • Dr. Ayman El-Kadi
  • Suebert, John (Pharmacy and Pharmaceutical Sciences)
    Clanachan, Alexander (Pharmacology)